GlassScriptPhysician profile
Lachlan M Smith
NPI 1477873065
$2,901.32
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,769 · 2020: $43.74 · 2022: $89.06.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $1,468.07 | 2019 | |
| Siemens Medical Solutions USA, INC. | $997.30 | 2019 | |
| Amgen INC. | $131.71 | 2019-2020 | |
| Heartflow, INC. | $89.06 | 2022 | |
| Seagen INC. | $53.10 | 2019 | |
| Novartis Pharmaceuticals Corporation | $51.08 | 2019-2020 | |
| Foundation Medicine, INC. | $33.64 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $20.98 | 2019 | |
| Celgene Corporation | $15.60 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $15.52 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.69 | 2019 | |
| Janssen Biotech, INC. | $11.57 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lachlan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.